Mirae Asset Global Investments’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-901,835
| Closed | -$660K | – | 2632 |
|
|
2022
Q3 | $660K | Sell |
901,835
-330,621
| -27% | -$242K | ﹤0.01% | 1718 |
|
|
2022
Q2 | $1.41M | Sell |
1,232,456
-12,785
| -1% | -$14.6K | ﹤0.01% | 1252 |
|
|
2022
Q1 | $2.55M | Sell |
1,245,241
-123,198
| -9% | -$253K | 0.01% | 1086 |
|
|
2021
Q4 | $3.94M | Buy |
1,368,439
+14,510
| +1% | +$41.8K | 0.01% | 947 |
|
|
2021
Q3 | $5.74M | Sell |
1,353,929
-284,471
| -17% | -$1.21M | 0.01% | 810 |
|
|
2021
Q2 | $8.67M | Buy |
1,638,400
+1,344,559
| +458% | +$7.11M | 0.02% | 692 |
|
|
2021
Q1 | $1.37M | Sell |
293,841
-356,040
| -55% | -$1.66M | ﹤0.01% | 1043 |
|
|
2020
Q4 | $2.15M | Buy |
649,881
+242,623
| +60% | +$801K | 0.01% | 900 |
|
|
2020
Q3 | $1.35M | Buy |
407,258
+54,466
| +15% | +$180K | 0.01% | 878 |
|
|
2020
Q2 | $1.19M | Buy |
352,792
+38,965
| +12% | +$131K | 0.01% | 848 |
|
|
2020
Q1 | $1.2M | Buy |
313,827
+11,032
| +4% | +$42.3K | 0.01% | 782 |
|
|
2019
Q4 | $1.83M | Sell |
302,795
-241,613
| -44% | -$1.46M | 0.01% | 769 |
|
|
2019
Q3 | $4.12M | Buy |
544,408
+139,848
| +35% | +$1.06M | 0.03% | 512 |
|
|
2019
Q2 | $5.48M | Buy |
+404,560
| New | +$5.48M | 0.04% | 435 |
|
|
2018
Q1 | – | Sell |
-361,062
| Closed | -$4.52M | – | 778 |
|
|
2017
Q4 | $4.52M | Buy |
361,062
+22,510
| +7% | +$282K | 0.06% | 195 |
|
|
2017
Q3 | $2.83M | Buy |
338,552
+35,442
| +12% | +$296K | 0.05% | 274 |
|
|
2017
Q2 | $5.14M | Buy |
+303,110
| New | +$5.14M | 0.09% | 149 |
|